HKSE:02159'
s Net Margin % Range Over the Past 10 Years
Min: -28.4 Med: 2.13 Max: 12.72
Current: 2.15
HKSE:02159's Net Margin % is ranked worse than 53.45% of 666
companies
in the Healthcare Providers & Services industry
Industry Median: 2.915
vs HKSE:02159: 2.15
Mediwelcome Healthcare Management & Technology (HKSE:02159) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Mediwelcome Healthcare Management & Technology Net Margin % Related Terms
Mediwelcome Healthcare Management & Technology Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mediwelcome Healthcare Management & Technology Net Margin % Chart
Mediwelcome Healthcare Management & Technology Annual Data
HKSE:02159 vs VEEV, BTSG, TEM: Net Margin % Comparison
For the Health Information Services subindustry, Mediwelcome Healthcare Management & Technology's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mediwelcome Healthcare Management & Technology Net Margin % vs Healthcare Providers & Services Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mediwelcome Healthcare Management & Technology (HKSE:02159) has a Net Margin % of 4.73% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Mediwelcome Healthcare Management & Technology and its competitors. This is 122% above median its historical median of 2.13. According to the industry distribution chart, Mediwelcome Healthcare Management & Technology ranks #356 out of 666 companies in the Healthcare Providers & Services industry, placing it in the top 53.5%.
Is Mediwelcome Healthcare Management & Technology's Net Margin % too high?
Mediwelcome Healthcare Management & Technology's current Net Margin % of 4.73% is 122% above median its 10-year median of 2.13. The Healthcare Providers & Services industry median Net Margin % is 2.92. Mediwelcome Healthcare Management & Technology's value of 4.73% is 62.3% above this industry median. Based on the distribution chart, Mediwelcome Healthcare Management & Technology ranks #356 out of 666 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Mediwelcome Healthcare Management & Technology has a GF Score™ of 54/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Mediwelcome Healthcare Management & Technology's Net Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Mediwelcome Healthcare Management & Technology ranks #356 out of 666 companies for Net Margin %. This places Mediwelcome Healthcare Management & Technology in the lower half of its industry. The industry median Net Margin % is 2.92. Mediwelcome Healthcare Management & Technology's value of 4.73% is 62.3% above this benchmark. While the company's 10-year median is 2.13 vs. the industry median of 2.92, Mediwelcome Healthcare Management & Technology has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Healthcare Providers & Services company?
The median Net Margin % among Healthcare Providers & Services companies is 2.92, based on 666 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mediwelcome Healthcare Management & Technology's current Net Margin % of 4.73% is 62.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Mediwelcome Healthcare Management & Technology and its competitors. For the Healthcare Providers & Services industry, the median Net Margin % is 2.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mediwelcome Healthcare Management & Technology's current Net Margin % is 4.73%, which is 122% above median its own 10-year median of 2.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mediwelcome Healthcare Management & Technology stock overvalued right now?
Based on GuruFocus' analysis, Mediwelcome Healthcare Management & Technology (HKSE:02159) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.69, compared to a current price of HK$1.62 — trading 134.8% above its estimated fair value. The current Net Margin % is 4.73%, which is 122% above median its 10-year median of 2.13 and 62.3% above the Healthcare Providers & Services industry median of 2.92. Mediwelcome Healthcare Management & Technology's overall GF Score™ is 54/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Mediwelcome Healthcare Management & Technology (HKSE:02159), the current Net Margin % is 4.73% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mediwelcome Healthcare Management & Technology (HKSE:02159) Overvalued in 2026?
Based on GuruFocus' analysis, Mediwelcome Healthcare Management & Technology stock appears to be overvalued.
The current stock price of HK$1.62 is trading 134.8% above its estimated GF Value™ of HK$0.69.
GuruFocus considers Mediwelcome Healthcare Management & Technology to be Significantly Overvalued.
Key valuation signals for HKSE:02159:
Net Margin %: 4.73% (122% above median its 10-year median of 2.13)
GF Value™: HK$0.69 vs. price of HK$1.62 (134.8% above fair value)
Industry Position: 62.3% above the Healthcare Providers & Services median (#356 of 666)
No single metric tells the full story. See the HKSE:02159 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mediwelcome Healthcare Management & Technology Business Description
Mediwelcome Healthcare Management & Technology Inc is an investment holding company. The Group mainly provides medical conference services, patient education and screening services, and marketing and consulting services, in addition to providing integrated healthcare marketing solutions. Its products and services include Academic Conference Management System, Scientific Research Data Reporting System, the Health/Medical Media Matrix, patient management services, and marketing and consulting services. The Group has only one reportable segment, mainly operating its businesses in the PRC and earning revenue from the PRC.
54GF Score
Get the complete analysis for HKSE:02159
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02159 has been successfully added to your 
